Join to View Full Profile
1365 Clifton Rd NEBldg BAtlanta, GA 30322
Phone+1 404-778-5210
Fax+1 404-778-3366
Dr. Koff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2016- Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
- Emory University School of MedicineClass of 2010
Certifications & Licensure
GA State Medical License 2012 - 2026
Clinical Trials
- A Study to Evaluate Tabelecleucel in Participants with Epstein-barr Virus-associated Diseases Start of enrollment: 2021 Jul 14
- Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29
Roles: Contact
Publications & Presentations
PubMed
- Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.Samuel Yamshon, Jean L Koff, Melissa C Larson, Brad S Kahl, Carla Casulo
American Journal of Hematology. 2025-04-01 - Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.Loretta J Nastoupil, Clark R Andersen, Amy Ayers, Yucai Wang, Thomas M Habermann
Clinical Lymphoma, Myeloma & Leukemia. 2025-04-01 - Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.Jonathan R Day, Melissa C Larson, Urshila Durani, Jean L Koff, Yucai Wang
Blood Advances. 2025-03-11
Press Mentions
The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with down SyndromeNovember 14th, 2024- Lab-Grown Human Immune System Can Check Cancer Patients’ Immune ResponsesNovember 13th, 2024
- Georgia Tech Researchers Create Lab-Grown Fashions of Human Immune MethodsNovember 12th, 2024
- Join now to see all
Grant Support
- Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway InhibitorsGEORGIA INSTITUTE OF TECHNOLOGY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
